SpliceBioGene therapySpliceBio lauches Phase I/II study on dual-AAV-based therapy for Stargardt DiseaseSpanish SpliceBio has dosed the first patient with SB-007, the first dual AAV gene therapy in clinical development for Stargardt disease more ➔
FSA UKCell-based meatRegulatory sandbox will speed up safety assessment of cell-based foodThe UK Food Standards Agency (FSA) has selected eight companies to participate in a two-year regulatory programme set to speed up market approval and safety assessment of cell-cultivated products. more ➔
asobe stock photos - catalin ObesityRoche inks US$1.65bn obesity deal with Zealand PharmaRoche is extending its obesity pipeline signing a US$5.3bn biobucks deal with Zealand Pharma A/S, who will co-develop and co-commercialise a monotherapy of its long-acting amylin analogue petrelintide … more ➔
Adobe stock - maurice norbert ObesityNovo Nordisk’s obesity drug CagriSema disappoints againNovo Nordisk A/S’ combined GLP1-, amylin- and calcitonin receptor agonist CagriSema has failed to meet the expected 25% weight loss within 68 weeks in the second of four pivotal Phase III trials. Shares … more ➔
Roche AGSLAS/AutomationRoche unveils completely new sequencing approachRoche researchers have introduced a greatly improved long-read nanopore sequencing method that has the potential to erase the sequencing-by-synthesis approach of market leader Illumina. more ➔
Hummingbird BioscienceFinancingADC maker Callio Therapeutics secures US$187m in Series A roundInvestment company Frazier Life Sciences has launched the virtual ADC company Callio Therapeutics Inc by licencing Hummingbird Bioscience’s TopDDRive dual payload ADC technology and co-leading a US$187m … more ➔
Audiovisual Library of the European CommissionEU CommissionEU Commission presents Clean Industrial DealThe European Commission has presented its long-awaited Clean Industrial Deal, which aims at replacing its Green Deal in times of geopolitical tensions, slow economic growth and technological competition … more ➔
Fuse VectorsPre-seed FinancingGene therapy manufacturing: Fuse Vectors secures US$5.2mFuse Vectors has secured US$5.2m in pre-seed financing to revolutionise gene therapy manufacturing with its cell-free viral vector technology. The Danish company is aiming to make treatments more accessible … more ➔
Ryvu Therapeutics zooCancer therapeuticsRyvu Therapeutics extends cashflow to consolidate pipelineKrakow-based oncology specialist Ryvu Therapeutics zoo today announced a strategic reorganisation that will extend Ryvu’s cash runway to H2/2026 to focus on accelerating three ongoing RVU120 clinical … more ➔
CSUElectionsNew German Chancellor wants a strong EuropeWith a 7.7% lead, the incoming Christian Democrat Chancellor Friedrich Merz has put the radical right-wing AfD in its place. Before forming a government in Germany, Merz emphasised that Germany wants … more ➔
SpliceBio
FSA UK
asobe stock photos - catalin 
Adobe stock - maurice norbert 
Roche AG
Hummingbird Bioscience
Audiovisual Library of the European Commission
Fuse Vectors
Ryvu Therapeutics zoo
CSU